|Year : 2012 | Volume
| Issue : 1 | Page : 12-16
TMC: A new staging system for tympanomastoid cholesteatoma
Aziz Belal, Mahmoud Reda, Ahmed Mehanna, Yousef Belal
Alexandria Ear Hospital, Alexandria, Egypt
|Date of Submission||18-Sep-2011|
|Date of Acceptance||29-Oct-2014|
|Date of Web Publication||13-Jun-2014|
Alexandria EarHospital, Alexandria
Source of Support: None, Conflict of Interest: None
To present a new staging system for tympanomastoid cholesteatoma that is based on the primary site of pathology in the middle ear (T), its spread to the mastoid (M), and to the surrounding structures, either cranial, intracranial, or extracranial, and presence of complications (C).
Tertiary Care Center (ENT Department, Faculty of Medicine, University of Alexandria, Egypt).
Clinical Prospective Study.
The TMC staging system is based on the correlation of preoperative otoscopy findings with computed tomography examination of the temporal bone. Preoperative findings have also been correlated with intraoperative findings.
We included 120 patients with tympanomastoid cholesteatoma diagnosed preoperatively.
In 87% of the patients, preoperative and intraoperative staging were well correlated.
The TMC staging system of cholesteatoma paves the way to a logical roadmap for functional surgery of the middle ear and mastoid; in addition, it makes the comparison of clinical studies about cholesteatoma meaningful.
Keywords: atticotomy, cholesteatoma, mastoid, mastoidectomy, tympanic cavity
|How to cite this article:|
Belal A, Reda M, Mehanna A, Belal Y. TMC: A new staging system for tympanomastoid cholesteatoma. Egypt J Otolaryngol 2012;28:12-6
|How to cite this URL:|
Belal A, Reda M, Mehanna A, Belal Y. TMC: A new staging system for tympanomastoid cholesteatoma. Egypt J Otolaryngol [serial online] 2012 [cited 2020 Feb 23];28:12-6. Available from: http://www.ejo.eg.net/text.asp?2012/28/1/12/129226
| Introduction|| |
Surgical strategy of tympanomastoid cholesteatoma may be based on factors related to the patient, surgeon, or disease. Patient factors include general factors, such as age, general medical status, and occupation and local factors, such as status of hearing, only one hearing ear, bilateral cholesteatoma, mastoid pneumatization, and eustachian tube function. Surgeon factors include preference and training of the surgeon at a particular time. Factors related to the disease include the anatomical site of origin, paths of spread inside and outside the temporal bone, histological characteristics and biological behavior of cholesteatoma. Pathology seems to be the most logical way to outline a surgical strategy for cholesteatoma ,,.
Why staging cholesteatoma?
Reviewing the techniques used to manage middle ear cholesteatoma showed that priority was given to the mastoid rather than the middle ear 3-6. However, histopathological and clinico-operative studies have shown that the involvement of middle ear is much higher than the mastoid in primary and revision cholesteatoma cases ,,,,. Thus, we have to empathize the concept that is based on tailoring the surgical technique according to the site of pathology and its extensions. Comparison of clinical and operative studies about tympanomastoid cholesteatoma always had the problem of finding a "standard" to make a meaningful comparison. Terms of small, big, and huge cholesteatomas made comparisons between the different studies like comparing apples to oranges.
A standard staging system will definitely solve this problem.
Attempts to stage tympanomastoid cholesteatoma
The classical etiological classification 7 of cholesteatoma into congenital, primary acquired, and secondary acquired cholesteatoma is an etiopathological classification and describes well the site of origin of cholesteatoma, its paths of spread, and its histological behavior.
Lau and Tos 8 otoscopically classified cholesteatoma into the following types: attic type in the pars flaccida of the eardrum; sinus cholesteatoma starting as a posterosuperior retraction or perforation of the pars tensa and extending to the tympanic sinus, posterior tympanum, and beyond; and tensa cholesteatoma presenting as retraction and adhesion of the entire pars tensa involving the tympanic orifice of the Eustachian tube (it may also extend further into the attic).
Tos and Lau 12 latter modified their classification into: attic, pars tensa I (marginal disease), and pars tensa II (central disease) cholesteatomas. Meyerhoff and Truelson  classified cholesteatoma into primary acquired, secondary acquired, tertiary acquired, and congenital cholesteatomas.
Saleh and Mills  introduced the Site-Ossicles-Complications classification System. It can be summarized as follows:
S1: if the cholesteatoma is restricted to the site where it had started.
S2: when the disease extends to another site.
S3: if it affects three sites.
S4: if it affects four sites.
S5: cases in which the primary site is affected plus four or more sites are also involved.
Authors distinguished seven sites used in this classification: attic, antrum, middle ear, mastoid, auditory tube, labyrinth, and middle fossa.
O0: if the ossicle chain is intact.
O1: if incus is eroded but without chain discontinuity.
O2: if incus and stapes suprastructures are eroded.
O3: if the malleus head and incus are absent and stapes superstructure is eroded.
C0: when there is no complication.
C1: if there is one complication.
C2: if there are two or more complications.
Regarding complications, the authors considered lateral semicircular canal fistula, facial palsy, total sensorineural auditory loss, sinus thrombosis, and intracranial invasion.
We thought that the latter staging system was very useful and well designed. However, it did not use and correlate to the computed tomography (CT) scanning, which has an important rule in studying the site of tympanomastoid cholesteatoma, in the staging system. It staged ears according to the status of ossicles, which is not a reliable factor because the final status of the ossicular chain cannot be assessed except after the disease has been completely eradicated. Furthermore, the previous staging system did not categorize complications into cranial and intracranial, which we think is an important point in staging.
New staging system for tympanomastoid cholesteatoma
After reviewing the previous staging system, and depending on our clinico-operative observations and experiences, we designed a new staging system for tympanomastoid cholesteatoma from stage 1 to stage 5 depending on the site of disease in the tympanic cavity (T), the mastoid cavity (M), and the presence of any complication (C). Staging of any case is made according to the official clinical (otoscopic/microscopic/endoscopic) examination, the radiological study (axial, coronal, and saggital reconstruction views of high-definition CT Petrous bone), and the clinicoradiological correlation. [Table 1] and [Table 2], [Figure 1].
A 40-year-old patient presented with recurrent discharging from the right ear.
Otoscopy: attic cholesteatoma and small polyp on one side of the head of malleus and normal mesotympanum (T1a).
CT scan: it showed attic cholesteatoma with the involvement of the mastoid cavity only in the antrum (M1).
There was no clinical or radiological manifestation of complications (C0).
Staging: T1M1C0=stage 3, intraoperative findings were corresponding to TMC staging [Figure 2].
A 24-year-old male patient presented with right ear hearing loss and occasional ear discharge.
Otoscopy: it showed a white pearly mass behind an intact tympanic membrane (T3).
CT scan: it showed a soft tissue mass in the tympanic cavity, with well-aerated mastoid (M0). The mass was eroding the basal turn of the cochlea (C1).
Staging: T3M0C1=stage 4, intraoperative findings were corresponding to TMC staging [Figure 3].
A 35-year-old male patient presented with persistent foul-smelling intermittent discharge from the right ear.
Otoscopy: it showed cholesteatoma involving the whole tympanic cavity (T4).
CT scan: it showed cholesteatoma filling the whole mastoid cavity (M2).
There was no clinical or radiological manifestation of complications (C0).
Staging: T4M2C0=stage 4, intraoperative findings were corresponding to TMC staging [Figure 4].
Correlation of preoperative and intraoperative findings
A total of 120 cases of tympanomastoid cholesteatoma examined and operated at the Alexandria Ear Hospital, Egypt in the period between 2005 and 2010 were included in this study. Cases were examined preoperatively (otoscopy, microscopy, and endoscopy), were CT scanned (coronal and sagittal views), and then were preoperatively staged according to the TMC staging system. Cases were operated upon and then staged again according to the intraoperative findings. Staging correlated well in 87% of cases. Preoperative staging underestimated the size of cholesteatoma in 11% of the cases and overestimated it in 1% of cases. [Table 2] summarizes the preoperative and intraoperative findings in these cases. MRI imaging of the temporal bone may help in better preoperative estimation of the size of cholesteatoma in future.
| Conclusion|| |
Although different staging systems for tympanomastoid cholesteatoma were described, they did not use the advances in CT scanning, they overestimate the importance of preoperative status of ossicles, and they did not categorize complications into cranial and intracranial. Our TMC staging system is a clinicoradiological system that depends on the correlation between preoperative and intraoperative findings. TMC staging can be used to plan a roadmap of functional surgery in cases of tympanomastoid cholesteatoma. Furthermore, it simplifies the terminology used to describe a case of tympanomastoid cholesteatoma. Thus, it facilitates a reliable type-specific comparison of published data reporting the results of tympanomastoid surgery. With the advances in the radiodiagnosis and histopathological technology, more tools of assessment of tympanomastoid cholesteatoma can be applied to design a more beneficial staging system in the future.
| Acknowledgements|| |
| References|| |
|1.||Graham MD, Delap TG, Goldsmith MM. Closed tympanomastoidectomy. Otolaryngol Clin North Am. 1999;32:547–554 |
|2.||Syms MJ, Luxford WM. Management of cholesteatoma: status of the canal wall. Laryngoscope. 2003;113:443–448 |
|3.||Kapur TR. Causes of failure of combined approach tympanoplasty in the treatment of acquired cholesteatomas of the middle ear and the mastoid. J Laryngol Otol. 1995;109:710–712 |
|4.||Reddy TN, Dutt SN, Shetty A, Maini S. Transcanal atticoaditotomy and transcortical mastoidectomy for cholesteatoma: the Farrior–Olaizola technique revisited. Ann Otol Rhinol Laryngol. 2001;110:739–745 |
|5.||Uzun C, Yagiz R, Tas A, Adali MK, Koten M, Karasalihoglu AR. Combined Heermann and Tos (CHAT) technique in cholesteatoma surgery: surgical technique and preliminary results. J Laryngol Otol. 2005;119:429–435 |
|6.||Dornhoffer JL. Retrograde mastoidectomy with canal wall reconstruction: a follow-up report. Otol Neurotol. 2004;25:653–660 |
|7.||Olszewska E, Wagner M, Bernal Sprekelsen M, Ebmeyer J, Dazert S, Hildmann H, et al. Etiopathogenesis of cholesteatoma. Eur Arch Otorhinolaryngol. 2004;261:6–24 |
|8.||Lau T, Tos M. Treatment of sinus cholesteatoma. Long-term results and recurrence rate. Arch Otolaryngol Head Neck Surg. 1988;114:1428–1434 |
|9.||Sethom A, Akkari K, Dridi I, Tmimi S, Mardassi A, Benzarti S, et al. Preoperative CT scan in middle ear cholesteatoma. Tunis Med. 2011;89:248–253 |
|10.||Alzoubi FQ, Odat HA, Al Balas HA, Saeed SR. The role of preoperative CT scan in patients with chronic otitis media. Eur Arch Otorhinolaryngol. 2009;266:807–809 |
|11.||Williams MT, Ayache D. Imaging in adult chronic otitis. J Radiol. 2006;87 (11 C2):1743–1754 |
|12.||Tos M, Lau T. Late results of surgery in different cholesteatoma types. ORL. 1989;51:33–49 |
|13.||Meyerhoff WL, Truelson J. Cholesteatoma staging. Laryngoscope. 1986;96 (9 I):935–939 |
|14.||Saleh HA, Mills RP. Classification and staging of cholesteatoma. Clin Otolaryngol Allied Sci. 1999;24:355–359 |
[Figure 1], [Figure 2], [Figure 3], [Figure 4]
[Table 1], [Table 2]